156 results
Type of content
News Remove News filter
Patient safety
Yes Remove Yes filter
-
List item
News: EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
CHMP, Last updated: 13/01/2023 -
List item
News: EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
PRAC, Last updated: 03/11/2022 -
List item
News: Hydroxyethyl-starch solutions for infusion recommended for suspension from the market
CMDh, Last updated: 26/07/2022 -
List item
News: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
PRAC, Last updated: 19/03/2021 -
List item
Press release: Update on review of valsartan medicines: risk from NDMA remains low, a related substance NDEA also being investigated
Last updated: 13/09/2018 -
List item
Press release: Update on review of valsartan medicines due to detection of NDMA: EMA reviewing valsartan produced by another company Zhejiang Tianyu
Last updated: 10/08/2018 -
List item
Press release: Esmya: new measures to minimise risk of rare but serious liver injury
Last updated: 08/08/2018 -
List item
Press release: Update on review of recalled valsartan medicines: preliminary assessment of possible risk to patients
Last updated: 02/08/2018 -
List item
Press release: EMA restricts use of prostate cancer medicine Xofigo
CHMP, Last updated: 27/07/2018 -
List item
Press release: Update on review of valsartan medicines following detection of impurity in active substance: assessing potential impact on patients is priority
Last updated: 17/07/2018 -
List item
Press release: EMA reviewing medicines containing valsartan from Zhejiang Huahai following detection of an impurity: some valsartan medicines being recalled across the EU
Last updated: 05/07/2018 -
List item
Press release: Hydroxyethyl starch solutions: CMDh introduces new measures to protect patients
CMDh, Last updated: 29/06/2018 -
List item
Press release: Esmya: new measures to minimise risk of rare but serious liver injury
CHMP, Last updated: 01/06/2018 -
List item
Press release: EMA review of Zinbryta confirms medicine's risks outweigh its benefits
PRAC, Last updated: 18/05/2018 -
List item
Press release: New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir
PRAC, Last updated: 18/05/2018 -
List item
Press release: Eye injuries in people and dogs when using Osurnia ear gel for dogs
CVMP, Last updated: 20/04/2018 -
List item
Press release: EMA reviewing risk of dosing errors with methotrexate
PRAC, Last updated: 13/04/2018 -
List item
Press release: Updated measures for pregnancy prevention during retinoid use
CHMP, Last updated: 23/03/2018 -
List item
Press release: Withdrawal of pain medicine flupirtine endorsed
CMDh, Last updated: 23/03/2018 -
List item
Press release: New measures to avoid valproate exposure in pregnancy endorsed
CMDh, Last updated: 23/03/2018 -
List item
Press release: Colour change for insulin injection Fiasp to avoid mix ups with Tresiba
Last updated: 23/03/2018 -
List item
Press release: Prostate cancer medicine Xofigo must not be used with Zytiga and prednisone/prednisolone
PRAC, Last updated: 09/03/2018 -
List item
Press release: EMA recommends immediate suspension and recall of multiple sclerosis medicine Zinbryta
Last updated: 07/03/2018 -
List item
Press release: EMA urgently reviewing multiple sclerosis medicine Zinbryta following cases of inflammatory brain disorders
PRAC, Last updated: 02/03/2018 -
List item
Press release: PRAC recommends new measures to avoid valproate exposure in pregnancy
PRAC, Last updated: 09/02/2018